Evidence map›Paper›PMID 24932751›Full record

ArticlePloS one2014

TCA cycle-mediated generation of ROS is a key mediator for HeR-MRSA survival under β-lactam antibiotic exposure.

Roberto R Rosato, Regina Fernandez, Liliana I Paz, Christopher R Singh, Adriana E Rosato

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. mLife · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Proteomic Response ofLife (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Article
  15. Comparative Proteomic Analysis ofTurkish journal of pharmaceutical sciences · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Roberto R RosatoCenter for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, United States of America.
Regina FernandezCenter for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, United States of America.
Liliana I PazCenter for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, United States of America.
Christopher R SinghCenter for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, United States of America.
Adriana E RosatoCenter for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, United States of America; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, United States of America.
Houston Methodist · US

Funding

B-lactam mediated SOS response and expression of resistance in clinical MRSAR01AI080688 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI ROSATO, ADRIANA E · 2010 to 2014
$2.0M
NIAID NIH HHS 5R01AI080688-03NIAID NIH HHS R01 AI080688
6 · The paper itself

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a major multidrug resistant pathogen responsible for several difficult-to-treat infections in humans. Clinical Hetero-resistant (HeR) MRSA strains, mostly associated with persistent infections, are composed of mixed cell populations that contain organisms with low levels of resistance (hetero-resistant HeR) and those that display high levels of drug resistance (homo-resistant HoR). However, the full understanding of β-lactam-mediated HeR/HoR selection remains to be completed. In previous studies we demonstrated that acquisition of the HoR phenotype during exposure to β-lactam antibiotics depended on two key elements: (1) activation of the SOS response, a conserved regulatory network in bacteria that is induced in response to DNA damage, resulting in increased mutation rates, and (2) adaptive metabolic changes redirecting HeR-MRSA metabolism to the tricarboxylic acid (TCA) cycle in order to increase the energy supply for cell-wall synthesis. In the present work, we identified that both main mechanistic components are associated through TCA cycle-mediated reactive oxygen species (ROS) production, which temporally affects DNA integrity and triggers activation of the SOS response resulting in enhanced mutagenesis. The present work brings new insights into a role of ROS generation on the development of resistance to β-lactam antibiotics in a model of natural occurrence, emphasizing the cytoprotective role in HeR-MRSA survival mechanism.

Indexed as

2,2'-DipyridylAdaptation, PhysiologicalAnti-Bacterial AgentsBacterial Proteinsbeta-Lactam Resistancebeta-LactamsCitric Acid CycleDNA, BacterialDNA DamageDrug Resistance, Multiple, BacterialGene Expression ProfilingMethicillin-Resistant Staphylococcus aureusMutation RateOxacillinPenicillin-Binding ProteinsReactive Oxygen Species2,2'-DipyridylAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsDNA, BacterialmecA protein, Staphylococcus aureusOxacillinPenicillin-Binding ProteinsReactive Oxygen SpeciesThiourea

Identifiers

PMID24932751
PMCPMC4059655
OpenAlexW2061354600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.